Can Washington legally turn CHIPS and Science Act money into equity stakes in quantum computing companies, or is the government trying to win the future by ignoring the statute that funds it? My view: the U.S. should invest aggressively in quantum computing, but not through deals that blur subsidy, procurement, venture capital, and industrial policy before Congress has clearly authorized the move.
The dispute centers on a $2 billion federal push into quantum companies, including $100 million investments in a range of startups and a much larger public-private bet around IBM and a new quantum chip foundry called Anderon, according to Ars Technica. That may be strategically tempting. It may even be technically useful. But if the legal foundation is shaky, Washington risks turning a quantum acceleration plan into a governance problem.
MLXIO already covered how this structure makes the U.S. more than a funder in $2B Quantum Computing Bet Turns US Into a Shareholder. The sharper question now is whether that shareholder turn was authorized in the first place.
Is the quantum race urgent enough to justify this kind of shortcut?
Yes, quantum computing deserves serious public money. No, urgency does not excuse legal improvisation.
The strategic case is straightforward. Useful error-corrected quantum computers remain years away, and Ars notes that the field may be closer to a decade from addressing some of the large, complex problems where the technology could see broad use. The additional security context is harder to ignore: sufficiently advanced quantum systems could threaten today’s encryption infrastructure, which turns quantum from a science project into a national-security priority.
That explains why policymakers want speed. The private market is unlikely to carry every viable technical path long enough for the field to find out which ones scale. Some companies will need patient capital before they have anything close to a mass-market product.
But panic is a bad allocator. The question is not whether the U.S. should fund quantum. It should. The question is whether officials can redirect money allocated for microelectronics R&D, with a focus on semiconductor technology, into equity-style quantum deals without Congress explicitly approving that use.
That is not a footnote. It is the whole fight.
Does Anderon solve a real bottleneck, or create a company before the market exists?
Anderon is the most ambitious part of the deal because it is not just funding another quantum startup. It is creating infrastructure.
IBM will put $1 billion into Anderon, matched by $1 billion from the government. IBM will also hand over “significant intellectual property, assets, and a skilled workforce,” according to the company’s announcement cited by Ars. The idea is to build something that resembles a foundry model: quantum firms design chips, Anderon fabricates them.
That makes sense on paper. IBM’s advantage in quantum has partly come from in-house materials science and fabrication capabilities. Those resources let IBM test alternate chip designs, iterate quickly, and refine what works. Ars notes that Google also opened its own fabrication facility, a sign that hardware control matters.
But the market Anderon wants to serve is not settled.
IBM specializes in transmons, one type of hardware that can host a qubit. Ars is clear that other companies funded in the same announcement are pursuing different approaches, including systems using very different hardware or no hardware at all. So a government-backed Anderon would not be neutral infrastructure in the broadest sense. It would tilt public money toward one category of quantum hardware.
| Anderon’s promise | Anderon’s risk |
|---|---|
| Faster iteration for companies designing transmon-based hardware | Early favoritism toward one technical path before the field settles |
| Higher-quality fabrication access than scattered test runs in less specialized fabs | Unproven demand for a dedicated quantum foundry over the long term |
| Shared manufacturing capability for firms without IBM-scale resources | Boom-and-bust exposure if chip demand concentrates in a few data centers |
That last point matters. Ars notes that transmons must operate at milliKelvin temperatures, and large-scale error-corrected systems may require chips chained across multiple refrigerated containers. If most usable machines sit in a limited number of data centers and are accessed online, the annual market for these chips may not look like the semiconductor market investors know. It could surge during buildouts, then thin out.
Can Congress let legality trail behind strategy?
It should not.
Representative Zoe Lofgren, the ranking Democrat on the House Science, Space, and Technology Committee, says the deal crosses a legal line. Her objection is not that quantum is unworthy. It is that Congress did not allocate this money for this purpose.
“This announcement is illegal and troubling on so many levels,” Lofgren said one day after the announcement.
Her argument has three parts. First, the money comes from the CHIPS and Science Act, which she says was allocated “specifically for microelectronics R&D, with a focus on semiconductor technology.” Second, she says the funds were meant to support public-private research partnerships, not equity stakes in quantum companies. Third, she raised concerns that the largest sum would go to IBM and suggested that Dario Gil, a former IBM executive and current Under Secretary for Science at the Department of Energy, was involved in negotiations.
Those claims deserve scrutiny, not dismissal as process whining.
Legality determines whether public money is allocated fairly, whether losing applicants can trust the process, and whether companies can build around the funding without fearing later reversal. If this deal is challenged, Ars notes the obvious path would be a lawsuit. But standing may be hard to establish, and even a plausible suit could take so long that the money would be spent before courts resolve the question.
That is the worst of both worlds: a deal controversial enough to damage trust, but too far advanced to unwind cleanly.
This is where tech policy often runs into law’s slower machinery. We saw another version of procedural stakes in MLXIO’s coverage of how Two Hours Crushed Musk’s OpenAI Case Against Altman. Different facts, different forum, same lesson: process can decide outcomes long before the technology argument gets heard.
Is Washington picking a quantum winner before quantum has picked one?
That is the sector risk.
Public money does more than fill a balance sheet. It signals legitimacy. It can pull talent, customers, and follow-on capital toward the government-backed path. In this case, that means the foundry model around transmon fabrication could gain an advantage before the market has proved it should.
The strongest counterargument is serious: transformative technologies often need public support before commercial demand is obvious. Ars itself says keeping some quantum companies viable over the next few years could be critical to giving competing technologies a full evaluation. A dedicated foundry could help transmon-focused startups access better hardware, reduce dependence on general fabs, and test designs faster.
That defense holds only if access is broad, terms are fair, and technical review is independent. Otherwise, industrial policy becomes a dressed-up way to subsidize one corporate architecture.
IBM may have its own rational reason to spin out fabrication now. Jay Gambetta, who leads IBM’s quantum efforts, has told Ars that current hardware error rates for IBM chips are where they need to be for the company to move forward with large-scale computing. If IBM believes it has already captured the main benefits of rapid internal iteration, letting the government cover half the cost of staff and facilities is financially attractive.
That may be smart business. It is not automatically sound public policy.
What would make this quantum bet defensible?
Congress and regulators should clean this up before the checks harden into precedent.
A lawful quantum strategy should include clear statutory authorization for equity-style investments, public disclosure of deal terms where possible, competitive access rules for Anderon, and independent technical review that is not captured by any one hardware camp. Funding should be tied to milestones: demonstrated external demand, measurable fabrication capability, fair access for qualified customers, and guardrails against monopoly control over publicly backed infrastructure.
The U.S. does not need to choose between speed and legality. It needs to prove they can reinforce each other.
Quantum computing may justify bold industrial policy. But the rule should be simple: if Washington wants to become a shareholder in the quantum race, Congress should say so plainly. The country should win by building faster and cleaner than its rivals — not by treating the law as something to correct after the money is gone.
Impact Analysis
- The legality of using CHIPS Act money for equity stakes could shape how far Washington can go in industrial policy.
- Quantum computing is a national-security priority because future systems may threaten today’s encryption.
- A shaky legal foundation could turn an urgent technology investment into a governance and accountability problem.
